Bernardo Marques

Bernardo Marques

Auto-generated profile, based on publicly available information

Bernardo Marques

University of Porto

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2013 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
AMAna Miguel
Ana Miguel
BMBernardo Marques
Bernardo Marques
AFAlberto Freitas
Alberto Freitas
FLFernando Lopes
Fernando Lopes
LALuís Azevedo
Luís Azevedo
APAltamiro Costa Pereira
Altamiro Costa Pereira

1 January 2010
Verified
Book Chapter
Closed access
PDF file
AFAlberto Freitas
Alberto Freitas
TST. Silva-Costa
T. Silva-Costa
BMB. Marques
B. Marques
ACA. Costa-Pereira
A. Costa-Pereira

1 January 2011
Verified
Conference Paper
Closed access
JGJuliano Gaspar
Juliano Gaspar
ECEmanuel Castro Cassoco Catumbela
Emanuel Castro Cassoco Catumbela
BMBernardo Marques
Bernardo Marques
AFAlberto Freitas
Alberto Freitas

1 January 2011
Verified
Book Chapter
Closed access
PDF file
AFAlberto Freitas
Alberto Freitas
TCTiago Costa
Tiago Costa
BMBernardo Marques
Bernardo Marques
JGJuliano Gaspar
Juliano Gaspar
JGJorge Gomes
Jorge Gomes
ILIsabel Lema
Isabel Lema

1 January 2013 in World Journal of Meta-Analysis
Verified
Journal Article
Open access
AMAna Miguel
Ana Miguel
FHFilipe Henriques
Filipe Henriques
BMBernardo Marques
Bernardo Marques
JMJoana Marques
Joana Marques
AFAlberto Freitas
Alberto Freitas
APAltamiro Costa Pereira
Altamiro Costa Pereira
AIM: To detect ophthalmic adverse drug reactions (ADRs), that occurred in Portugal from 2000 to 2009, through the utilization of administrative hospital databases. We also intended to compare the results of this methodology with spontaneous reporting. METHODS: We conducted a retrospective nationwide study using hospital administrative databases, which included all inpatients and outpatients in all public hospitals in Portugal, from 2000 to 2009. We used International Classification of Diseases - 9th Revision - Clinical Modification (ICD-9-CM) coding data that allowed the detection of ADRs. We used WHO’s definition for ADR. We searched all of ICD-9-CM terms in Ophthalmology for codes that included “drug-induced”, “iatrogenic”, “toxic” and all other that could signal an ADR, such as “362.55 - toxic maculopathy” or “365.03 - steroid responders”, and also “E” codes (codes from E930 to E949.9, that exclude intoxications and errors). RESULTS: From 11944725 hospitalizations or ambulatory episodes within that period of time, we identified 1524 probable ophthalmic ADRs (corresponding to a frequency of 1.28 per 10000 episodes) and an additional 100 possible ophthalmic ADRs. We used only 4 person-hours in the application of this methodology. A total of 113 spontaneous reports arose from ophthalmic ADRs from 2000 to 2009 in Portugal (frequency of 0.095 per 10000 episodes).To our knowledge, this was the first estimate of the frequency of ophthalmic ADRs through the use of databases, and the first nationwide estimate of ophthalmic ADRs, in Portugal. We identified 1524 probable ADRs and 100 possible ADRs. CONCLUSION: This database methodology adapted for Ophthalmology may represent a new approach for the detection of ophthalmic ADRs, since these codes exist in the ICD-9-CM classification. Its performance was clearly superior to spontaneous reporting.

1 January 2012
Verified
Conference Paper
Closed access
BMBernardo Marques
Bernardo Marques
ESEliana Sousa
Eliana Sousa
TSTiago Silva-Costa
Tiago Silva-Costa
RCRicardo João Cruz-Correia
Ricardo João Cruz-Correia
AFAlberto Freitas
Alberto Freitas